CLINICAL_TRIALS
trial_result
· 2016-05-02
Clinical Trial Update: Treatment of Cancer-associated Anorexia Using Megestrol Acetate Concentrated Suspension [Phase 3]
Summary
Phase 3 trial of Megestrol Acetate Concentrated Suspension for cancer-associated anorexia was terminated, with results posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Par Pharmaceutical, Inc. | Conditions: Anorexia, Cachexia | Phase 3 | Status: TERMINATED | Results posted: 2016-05-02